Skip to main content
SpringerLink
Log in

Diacerein

A Viewpoint by Dino Benetti and Maurizio Mian

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Group for the Respect of Ethics and Excellence in Science. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 1996; 55: 552–7

    Article  Google Scholar 

  2. Doherty M, Jones A. Indomethacin hastens large joint OA in humans — how strong is the evidence? J Rheumatol 1995; 22: 2013–6

    PubMed  CAS  Google Scholar 

  3. Lequesne M, Brandt TK, Bellamy N, et al. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol 1994; 21Suppl. 41: 65–71

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto Gentili, Pisa, Italy

    Dino Benetti & Maurizio Mian

Authors
  1. Dino Benetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurizio Mian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benetti, D., Mian, M. Diacerein. Drugs 53, 107–108 (1997). https://doi.org/10.2165/00003495-199753010-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199753010-00009

Keywords

Search

Navigation